Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yumi Aoyama

Showing results (1-10 of 115) with videos related to

Pageof 12
Sort By:
Nihon Rinsho. Japanese Journal of Clinical Medicine|August 17, 2012
[How intravenous immunoglobulin therapy works in pemphigus]Yumi Aoyama
The Journal of Dermatology|May 29, 2010
What's new in i.v. immunoglobulin therapy and pemphigus: high-dose i.v. immunoglobulin therapy and its mode of action for treatment of pemphigusYumi Aoyama
Clinical and Experimental Dermatology|May 9, 2024
Immune reconstitution is the trigger of herpes zoster with lymphopenia and high neutrophil-to-lymphocyte ratio in a retrospective cohort studyTakenobu Yamamoto, Yumi Aoyama
Clinical Reviews in Allergy & Immunology|December 21, 2007
A perspective of pemphigus from bedside and laboratory-benchYasuo Kitajima, Yumi Aoyama
The Journal of Dermatology|April 29, 2026
Drug-Induced Blaschkitis Associated With Dipeptidyl Peptidase-4 Inhibitor: A Case Report and Review of the LiteratureYasunori Suzaki, Yumi Aoyama
The Journal of Dermatology|August 6, 2021
Role of pro-inflammatory cytokines in the pathophysiology of herpes simplex virus superinfection in Darier's diseaseTakenobu Yamamoto, Yumi Aoyama
The Journal of Dermatology|September 17, 2020
Detection of multinucleated giant cells in differentiated keratinocytes with herpes simplex virus and varicella zoster virus infections by modified Tzanck smear methodTakenobu Yamamoto, Yumi Aoyama
Case Reports in Dermatology|April 1, 2021
Varicella Zoster Virus-Associated Meningitis as a Rebound Varicella Zoster Disease after Antiviral DiscontinuationTetsuko Sato, Takenobu Yamamoto, Yumi Aoyama
Pharmaceuticals (Basel, Switzerland)|July 27, 2022
Anti-Cytomegalovirus Therapy: Whether and When to Initiate, Those Are the QuestionsYumi Aoyama, Seiko Sugiyama, Takenobu Yamamoto
Journal of Dermatological Science|January 25, 2023
Intravenous immunoglobulin in patients with bullous pemphigoid insufficient response to corticosteroids: Nationwide post-marketing surveillance in JapanHideyuki Ujiie, Makoto Arakawa, Yumi Aoyama
Pageof 12

Showing results (1-10 of 115) with videos related to

Sort By:
Pageof 12
Nihon Rinsho. Japanese Journal of Clinical Medicine|August 17, 2012
[How intravenous immunoglobulin therapy works in pemphigus]Yumi Aoyama
The Journal of Dermatology|May 29, 2010
What's new in i.v. immunoglobulin therapy and pemphigus: high-dose i.v. immunoglobulin therapy and its mode of action for treatment of pemphigusYumi Aoyama
Clinical and Experimental Dermatology|May 9, 2024
Immune reconstitution is the trigger of herpes zoster with lymphopenia and high neutrophil-to-lymphocyte ratio in a retrospective cohort studyTakenobu Yamamoto, Yumi Aoyama
Clinical Reviews in Allergy & Immunology|December 21, 2007
A perspective of pemphigus from bedside and laboratory-benchYasuo Kitajima, Yumi Aoyama
The Journal of Dermatology|April 29, 2026
Drug-Induced Blaschkitis Associated With Dipeptidyl Peptidase-4 Inhibitor: A Case Report and Review of the LiteratureYasunori Suzaki, Yumi Aoyama
The Journal of Dermatology|August 6, 2021
Role of pro-inflammatory cytokines in the pathophysiology of herpes simplex virus superinfection in Darier's diseaseTakenobu Yamamoto, Yumi Aoyama
The Journal of Dermatology|September 17, 2020
Detection of multinucleated giant cells in differentiated keratinocytes with herpes simplex virus and varicella zoster virus infections by modified Tzanck smear methodTakenobu Yamamoto, Yumi Aoyama
Case Reports in Dermatology|April 1, 2021
Varicella Zoster Virus-Associated Meningitis as a Rebound Varicella Zoster Disease after Antiviral DiscontinuationTetsuko Sato, Takenobu Yamamoto, Yumi Aoyama
Pharmaceuticals (Basel, Switzerland)|July 27, 2022
Anti-Cytomegalovirus Therapy: Whether and When to Initiate, Those Are the QuestionsYumi Aoyama, Seiko Sugiyama, Takenobu Yamamoto
Journal of Dermatological Science|January 25, 2023
Intravenous immunoglobulin in patients with bullous pemphigoid insufficient response to corticosteroids: Nationwide post-marketing surveillance in JapanHideyuki Ujiie, Makoto Arakawa, Yumi Aoyama
Pageof 12